Overview
Zheng Topp is a Hematologist Oncology specialist and an Oncologist in Portland, Oregon. Dr. Topp is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Angiosarcoma. Dr. Topp is currently accepting new patients.
Her clinical research consists of co-authoring 3 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has participated in 1 clinical trial in the study of Breast Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- PPO
- EPO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Zahi Mitri is an Oncologist and a Hematologist Oncology provider in Portland, Oregon. Dr. Mitri is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. His top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Paget Disease of the Breast, and Angiosarcoma.
Alison Conlin is an Oncologist in Portland, Oregon. Dr. Conlin is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, Endoscopy, and Colonoscopy. Dr. Conlin is currently accepting new patients.
David Page is an Oncologist in Portland, Oregon. Dr. Page has been practicing medicine for over 17 years and is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Angiosarcoma. Dr. Page is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Breast CancerDr. Topp isDistinguished. Learn about Breast Cancer.
- Paget Disease of the BreastDr. Topp isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- AngiosarcomaDr. Topp isAdvanced. Learn about Angiosarcoma.
- Inflammatory Breast CancerDr. Topp isAdvanced. Learn about Inflammatory Breast Cancer.
- Experienced
- Acute Eosinophilic PneumoniaDr. Topp isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Mountain SicknessDr. Topp isExperienced. Learn about Acute Mountain Sickness.
- ALK-Positive Non-Small Cell Lung Cancer
- Ampullary CancerDr. Topp isExperienced. Learn about Ampullary Cancer.
- AnemiaDr. Topp isExperienced. Learn about Anemia.
- Angioimmunoblastic T-cell LymphomaDr. Topp isExperienced. Learn about Angioimmunoblastic T-cell Lymphoma.